Nuvig Therapeutics Appoints Julie Smith Chief Executive Officer

by on January 4, 2023

Redwood City, Calif., January 4, 2023 – Nuvig Therapeutics, Inc., a biopharma company developing proprietary recombinant human therapeutics for patients with autoimmune diseases, today announced the appointment of Julie Anne Smith as Chief Executive Officer (CEO) and member of the Board of Directors. Ms. Smith has over 20 years of experience in the life science…